Latest News

12
May
2015

Doctors are influential in encouraging people to exercise more but bowel cancer patients shouldn't wait for that advice.

According to a large UK study of more than 15,000 bowel cancer patients, less than a third of patients (31%) recall receiving advice on physical activity from their doctors.

This is despite the evidence that physical activity can alleviate symptoms such as cancer-related fatigue, improve quality of life, reduce cancer recurrence rates and extend survival.

19
May
2015
 
Cronulla Sharks backrower and Bowel Cancer Australia ambassador Chris Heighington has teamed up with the NRL to promote a wider awareness of the 'silent killer'. Heighington first partnered with Bowel Cancer Australia near on two years ago, upon hearing that his Father had been diagnosed with the disease in 2012. 'Heighno' joins a host of NRL personalities - both past and present - in promoting bowel cancer awareness on the quest to improve Australia's state of poor colorectal health.
 
 
18
May
2015
 
Commonwealth Laboratories, Inc. has announced the availability of IBSchek™, a new blood test designed to help physicians quickly and reliably diagnose Irritable Bowel Syndrome (IBS). Within 24 hours of receiving the blood specimen, the test identifies the presence of two antibodies - anti-CdtB and anti-vinculin, which recent data have shown to be indicative of diarrhea-prominent IBS. These data, which will be presented during an oral session at Digestive Disease Week® 2015 in Washington, D.C., show that for the first time ever, researchers have identified an organic biomarker for the diagnosis of IBS. Prior to the introduction of IBSchek™, a diagnosis of IBS was typically made after excluding all other conditions. This often requires multiple costly diagnostic tests over an average of five years to rule out other conditions before coming to a confident diagnosis of IBS.
18
May
2015
 
A multicenter study published in the peer-reviewed journal Alimentary Pharmacology and Therapeutics shows that a new molecular test accurately detects changes in gut microbiota called dysbiosis. With increasing interest in the Human Microbiome and evidence that dysbiosis is implicated in major diseases, including Irritable Bowel Syndrome, Inflammatory Bowel Diseases, obesity and diabetes II the researchers believe that new GA-map™ Dysbiosis Test will help physicians to improve diagnosis and treatment of patients.
17
May
2015
 
A cancer diagnosis provides an education like no other. In 2007, at the age of 28, I was diagnosed with bowel cancer. It can rightly be called New Zealand's cancer it kills more New Zealanders than breast and prostate cancers combined and we have one of the highest rates of occurrence and death from the disease in the OECD.
 
Nearly 3000 Kiwis are diagnosed annually and, of these, about 1200 will die that's 100 men and women every month. Bowel cancer is the major reason New Zealand's cancer death rate is 10 per cent higher than Australia's.
Page 1 of 132